RealCold acquires SCL Cold Chain to break into pharma logistics
What's the deal? RealCold has acquired SCL Cold Chain, a move that expands the cold storage company's footprint into pharmaceutical logistics. The deal marks RealCold's entry into a new vertical beyond its traditional food-focused cold chain operations.
Why now? The pharmaceutical cold chain market has been growing rapidly, driven by the rising demand for temperature-sensitive biologics, vaccines, and gene therapies. Companies with existing cold storage infrastructure are well positioned to capture this adjacent market.
What could go wrong? Pharmaceutical logistics comes with far stricter regulatory requirements than food cold chain — including GDP (Good Distribution Practice) compliance and rigorous documentation standards. Integrating SCL's pharma-grade operations while maintaining service quality across both businesses will be a key challenge.
The signal: The acquisition reflects a broader trend of cold chain operators diversifying beyond food into higher-margin, faster-growing pharmaceutical logistics. As biologics and personalised medicine expand, demand for specialised temperature-controlled supply chains will only intensify — making pharma cold chain an increasingly attractive target for consolidation.
Read more: prnewswire.com
